3 active not recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 3 |
Follow Opioid Use Disorder: new trials by email Literature Review of Opioid Use Disorder trials Research Report on Opioid Use Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-dose Versus a High-dose Sublingual Buprenorphine Induction buprenorphine/naloxone - Opioid Use Disorder | Phase 4 | Active not recruiting | Friends Research Institute, Inc. | 40 | 2024-06-20 | 2025-08-12 |
| Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment Patient-Oriented Dosing (POD), Pain Self-Management (PSM), Usual Care - Opioid Use Disorder, Chronic Pain | Phase 4 | Active not recruiting | Erin Winstanley | 273 | 2024-05-28 | 2026-08-18 |
| Personalization of Opioid Prescription Following Orthognathic Surgery Personalization of dose and frequency and instituting a tapering protocol of hydromorphone post-orthognathic surgery, Standardized dose and frequency of hydromorphone with no tapering post-orthognathic surgery - Pain, Postoperative, Orthognathic Surgery | Phase 4 | Active not recruiting | Nova Scotia Health Authority | 201 | 2023-04-24 | 2025-08-14 |
Opioid-Related Disorders (3) · Chronic Pain (1) · Pain, Postoperative (1) · Patient Satisfaction (1)
Chemically-Induced Disorders (3) · Mental Disorders (3) · Narcotic-Related Disorders (3) · Substance-Related Disorders (3) · Neurologic Manifestations (2) · Pain (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Behavior (1) · Health Behavior (1) · Pathologic Processes (1) · Postoperative Complications (1) · Treatment Adherence and Compliance (1)
Buprenorphine, Naloxone Drug Combination (1)
Erin Winstanley (1) · Friends Research Institute, Inc. (1) · Nova Scotia Health Authority (1)
United States (2) · Canada (1)
Amr Alsabbagh, DDS (1) · Erin L Winstanley, PhD (1) · Jean-Charles Doucet, DMD, MD, MSc (1)
RM1DA055311 (1)